论文信息 - Mutational complexity increases in lung adenocarcinoma (LADC) with the development of brain metastasis (BM).

Mutational complexity increases in lung adenocarcinoma (LADC) with the development of brain metastasis (BM).

2067Background: Up to 40% of LADC patients (pts) develop BM but little is known about the inciting molecular events. Methods: We compared mutational profiles of LADC BM pts with primary (P) LADC su...

[1] J. Szustakowski,et al. Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden , 2018, The New England journal of medicine.

[2] J. Marshall,et al. Microsatellite instability status determined by next‐generation sequencing and compared with PD‐L1 and tumor mutational burden in 11,348 patients , 2018, Cancer medicine.

[3] Ahmet Zehir,et al. Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4] S. Peters,et al. The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer. , 2016, Cancer treatment reviews.

[5] H. Hansen,et al. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.